An observational study in Chronic Obstructive Pulmonary Disease, sponsored by Schön Klinik Berchtesgadener Land. Completed at 2 sites in Germany. Open to participants aged 40 Years to 75 Years. Per ClinicalTrials.gov, last updated 2025-04-30.
Sponsored by Schön Klinik Berchtesgadener Land · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 36 studies in Pulmonary Disease, Chronic Obstructive by Schön Klinik Berchtesgadener Land — none open to participants now, 1 under way, none of them phase 3. Pulmonary Disease, Chronic Obstructive · Schön Klinik Berchtesgadener Land.
Among the 36 studies in Pulmonary Disease, Chronic Obstructive by Schön Klinik Berchtesgadener Land, this one is one of 3 that started in 2020, is one of 5 observational ones, and was the 35th registered.
5,529 studies on the registry are indexed under Pulmonary Disease, Chronic Obstructive; 858 are open to participants now.
Browse Pulmonary Disease, Chronic Obstructive studies →None of the 36 studies in Pulmonary Disease, Chronic Obstructive by Schön Klinik Berchtesgadener Land is open now. The open studies under Pulmonary Disease, Chronic Obstructive, anywhere →
Of the 560 Pulmonary Disease, Chronic Obstructive studies recruiting now, 307 (55%) set no upper age limit and 82 (15%) stop at 75 or younger; 30 take children under 18; 88 take healthy volunteers.
This study: 40 Years to 75 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
36 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 3 started in 2020.
This study's enrollment of 130 is below the median of 159 across 1,498 observational studies indexed under Pulmonary Disease, Chronic Obstructive.
Median enrollment 44 across the 31 interventional studies, 130 across the 5 observational. Of the 29 that completed or were terminated, 3 (10%) have results posted.
This tab as a report to print or save as PDF → With an account.
Schön Klinik Berchtesgadener Land is the lead sponsor of 51 studies on the registry; 2 are open to participants now.
None of the studies under way reaches primary completion within a year.
Among the 36 studies in Pulmonary Disease, Chronic Obstructive by Schön Klinik Berchtesgadener Land, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Up tp now, disease activity of COPD patients in their home environment has usually been recorded by questionnaires (e.g. COPD assessment test). Digital multifactorial measurements, via the "mobile COPD Status test" app, offer a new way of displaying disease activity. However, there is no independent study that has examined whether digitally collected parameters correlate with the common used measurement instruments for COPD patients (both in cross-sectional and longitudinal course).
The aim of this exploratory study is to investigate the correlation between the mobile COPD Status test (mCST App, KAIA Health) and a conventional collected clinical data set of routine measurements as well as the subjective symptoms and activity perception of COPD patients in their home environment, with and without exacerbation.
In total 130 COPD patients will be included prospectively in this multicenter trial during an inpatient pulmonary rehabilitation program at the Schoen Klinik Berchtesgadener Land, Schönau am Koenigssee, (Germany) or during a stay (inpatient or outpatient) at the Klinikum Nuremberg (Germany).
In general, the study is divided into two parts - study part I, within the duration of the pulmonary rehabilitation program/ hospital stay and study part II, in the home environment (24 weeks).
Study part I:
Visit 1 (day 0, in the clinic) + Visit 2* (day 14+/-5, in the clinic/outpatient)
Each study participant is given a smartphone. Under the guidance of study personnel, data collection of the following parameters is carried out via KAIA mCST App):
The mCST app takes about 15 minutes to complete.
Additionally, clinical routine data will be collected:
Study part II:
Visits 3 to 26 (week 3 to 26, in participants home environment) From study visit 3 on, participants are observed weekly in their home environment for a total of 24 weeks. No further clinic visits take place. Disease activity is measured weekly as patient reported outcomes using the mCST app (for details see description of visit 1/2, part 1). In addition to the weekly mCST app, patients are invited to fill out daily a symptom diary before going to bed. The symptom diary contains the EXACT questionnaire and an activity questionnaire.
*Visit 2 is optional
COPD patients
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Other: usual medical care
Prospective monitoring of clinical Outcomes and digital collected outcomes via the mobile COPD staus test app.
Correlation between usual physical exercise tests and exercise test measured via mobile COPD status test app (mCST)
Correlation between the 6-minute walk test distance (clinical routine) and the number of repetitions of the 1-minute sit-to-stand-test (mCST app)
Time frame: Visit 1 (Day 0)
Correlation between usual physical exercise tests and exercise test measured via mobile COPD status test app (mCST)
Correlation between the 6-minute walk test distance (clinical routine) and the number of repetitions of the 1-minute sit-to-stand-test (mCST app)
Time frame: if applicable Visit 2 (Day 14)
Correlation between COPD Assessment test and perception of disease activity measured via mobile COPD status test app (mCST)
Correlation between standardized questions about COPD activity/ symptoms via the mCST app and the COPD Assessment Test
Time frame: weekly up to 26 weeks (Visit 1 to Visit 26)
Correlation between modified medical research scale (mMRc) and perception of dyspnea measured via mobile COPD status test app (mCST)
Correlation between standardized questions about dyspnea collected via the mCST app and the modified medical research scale
Time frame: Visit 1 (Day 0)
Correlation between modified medical research scale (mMRc) and perception of dyspnea measured via mobile COPD status test app (mCST)
Correlation between standardized questions about dyspnea collected via the mCST app and the modified medical research scale
Time frame: if applicable Visit 2 (Day 14)
Correlation between lung function parameters and inspiratory-/expiratory duration measured via mobile COPD status test app (mCST)
Correlation between inspiratory-/ expiratory duration via the mCST app and FEV1, RV, TLC, VC
Time frame: Visit 1 (Day 0)
Correlation between lung function parameters and inspiratory-/expiratory duration measured via mobile COPD status test app (mCST)
Correlation between inspiratory-/ expiratory duration via the mCST app and FEV1, RV, TLC, VC
Time frame: if applicable Visit 2 (Day 14)
Correlation between mCST app and symptom diary (EXACT questionnaire)
Correlation between standardized questions about COPD activity/symptoms via the mCST app and the EXACT questionnaire, which consists of 14 questions to quantify exacerbations.
Time frame: weekly up to 26 weeks (Visit 1 to Visit 26)
Correlation between mCST app and symptom diary (Freiburger activity questionnaire)
Correlation between standardized questions about COPD activity/ symptoms via the mCST app and the Freiburger activity questionnaire, which consists of 12 items and measures the duration and frequency of various basic, everyday and sports activities of the past week
Time frame: weekly up to 26 weeks (Visit 1 to Visit 26)
Differences in outcomes of the mobile COPD status test app (mCST) between patients without and with exacerbations during the study period
Change in the mCST app parameters during the trial period in stable COPD patients an COPD patients with an acute exacerbations during the study period
Time frame: weekly up to 26 weeks (Visit 1 to Visit 26)
Plan to share: No
No publications or documents are linked to this record.
Ran from Aug 2020 to primary completion in Jul 2023, 35 months.
Of 469 non-industry observational studies under Pulmonary Disease, Chronic Obstructive, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 62. This study's 35 months is above that.
Counting every sponsor, half of 589 studies reached it within 26 months; a quarter within 14 and three quarters within 57.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Pulmonary Disease, Chronic Obstructive →
Schön Klinik Berchtesgadener Land